June 16, 2020 / 5:42 AM / 20 days ago

BRIEF-Eli Lilly Says FDA Approves its New Rapid-Acting Insulin Lyumjev (Insulin Lispro-Aabc Injection)

June 16 (Reuters) - Eli Lilly and Co:

* FDA APPROVES LYUMJEV (INSULIN LISPRO-AABC INJECTION), LILLY’S NEW RAPID-ACTING INSULIN

* LYUMJEV TO BE INCLUDED IN LILLY INSULIN VALUE PROGRAM ALLOWING THOSE WITHOUT INSURANCE AT ALL TO FILL MONTHLY PRESCRIPTION FOR $35 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below